A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine

How I treat thalassemia

(2011) E. A. Rachmilewitz et al.   BLOOD

Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome

(2011) Hussam Ghoti et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hepcidin in Human Iron Disorders: Diagnostic Implications

(2011) J. J. C. Kroot et al.   CLINICAL CHEMISTRY

Importance of Iron Chelation in Free Radical-Induced Oxidative Stress and Human Disease

(2011) Klaudia Jomova et al.   CURRENT PHARMACEUTICAL DESIGN

Iron-Chelating Therapy for Transfusional Iron Overload

(2011) Gary M. Brittenham   NEW ENGLAND JOURNAL OF MEDICINE

The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia

(2010) Eitan Fibach et al.   Annals of the New York Academy of Sciences

The iron-chelating potential of silybin in patients with hereditary haemochromatosis

(2010) C Hutchinson et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Chelating, antioxidant and hypoglycaemic potential ofMuscari comosum(L.) Mill. bulb extracts

(2010) Monica R. Loizzo et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids

(2010) C. Thephinlap et al.   Medicinal Chemistry

Flavonoids and antioxidant activity of Rosa agrestis leaves

(2010) Leyla Bıtıs et al.   NATURAL PRODUCT RESEARCH

Combined therapy of silymarin and desferrioxamine in patients with β-thalassemia major: a randomized double-blind clinical trial

(2009) Marjan Gharagozloo et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Synthetic and natural iron chelators: therapeutic potential and clinical use

(2009) Heather C Hatcher et al.   Future Medicinal Chemistry

Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C

(2008) Julie M. Bares et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY